Nachrichten zur HEMOGENYX PHARM.PLC LS-01 Aktie

Hemogenyx Pharmaceuticals gets greenlight for clinical trial

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) told investors it has received Institutional Review Board (IRB) approval to begin a Phase I…

Hemogenyx receives £600,000 institutional boost

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF), the biopharmaceutical company developing treatments for blood diseases, has secured £600,000 in funding...…

Hemogenyx Pharmaceuticals provides timeline for trial of potentially breakthrough leukaemia treatment

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) has announced the timeline for its upcoming phase I clinical trial of HEMO-CAR-T, a new treatment for...…

Hemogenyx Pharmaceuticals up 9% after it receives further investment from partner Prevail

Shares in Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) rose 9% after it secured a new $350,000 investment from Prevail Partners, an investment fund,...…

Hemogenyx Pharmaceuticals up 9% after it receives further investment from partner Prevail

Shares in Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) rose 9% after it secured a new $350,000 investment from Prevail Partners, an investment fund,...…

Hemogenyx Pharmaceuticals readies for phase I trial

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) confirmed it is in the final stages of opening a clinical site ahead of a…

Hemogenyx Pharmaceuticals passes crucial milestone ahead of phase I trial

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) has developed a clinical-grade assay to measure FLT3 protein levels in acute myeloid leukaemia (AML)...…

Hemogenyx Pharmaceuticals hails potential of new CDX antibody

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) has announced the development of a new version of its bi-specific CDX antibody aimed at…

Hemogenyx Pharmaceuticals CEO discusses progress with across clinical programs

…

Hemogenyx Pharmaceuticals issues operational update

Hemogenyx Pharmaceuticals provided an update on its cancer and viral disease treatment activities and progress on Monday, detailing the expansion…

Hemogenyx adds new trial site; making progress on multiple fronts

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF), the clinical-stage biopharmaceutical group developing treatments for cancers and viral diseases, said...…

Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023

…

Hemogenyx Pharmaceuticals reflects on ‘vital year’, eyes number of strategies to advance its clinical opportunities

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) chair Marc Feldmann, in the company’s final results statement, described the year as a “period…

Hemogenyx Pharmaceuticals reflects on ‘vital year’, eyes number of strategies to advance its clinical opportunities

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) chair Marc Feldmann, in the company’s final results statement, described the year as a “period…

Hemogenyx Pharmaceuticals important raise and CAR-T potential makes it one to watch

In a recent article, I said at least 20 micro-cap life sciences stocks were waiting to pop once interest returned…

Hemogenyx Pharmaceuticals important fund raise and CAR-T potential makes it one to watch

In a recent article, I said at least 20 micro-cap life sciences stocks were waiting to pop once interest returned…

Hemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T program

…

Hemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platform

…

Hemogenyx shares jump 16% on nasal delivery news

Shares in HemoGenyx Pharmaceuticals (LSE:HEMO) PLC rose 16% following the announcement that its chimeric bait receptor (CBR) technology for combatting...…

HemoGenyx Pharma soars on FDA trial consent

Shares in HemoGenyx Pharmaceuticals (LSE:HEMO) PLC soared over 17% on Friday morning on news the company’s trials of myeloid leukaemia…

Hemogenyx Pharmaceuticals gets extra US patent protection for CDX

HemoGenyx Pharmaceuticals (LSE:HEMO) PLC said a "significant" application made with the United States Patent and Trademark Office has been approved to...…

Hemogenyx shares make early bright start after cancer update

Shares in HemoGenyx Pharmaceuticals (LSE:HEMO) PLC jumped 10% following their announcement about the potential cancer treatment applications of its Chimeric...…

Hemogenyx slapped with FDA clinical hold on CAR-T therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Hemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDA

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hemogenyx Pharmaceuticals Addresses FDA Concern on Leukemia Treatment; Shares Rise

Hemogenyx Pharmaceuticals Addresses FDA Concern on Leukemia Treatment; Shares Rise...…

Hemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T IND

LONDON, UK / ACCESSWIRE / July 10, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and…

Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting

Result of Annual General MeetingLONDON, UK / ACCESSWIRE / July 3, 2023 / Hemogenyx Pharmaceuticals plc is pleased to announce…

Hemogenyx Pharmaceuticals PLC Announces Posting of Annual Report & Notice of AGM

LONDON, UK / ACCESSWIRE / June 2, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group, confirms that the Annual…

IN BRIEF: Hemogenyx announces clinical hold for Hemo-Car-T treatment

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-T

Hemogenyx Pharmaceuticals Announces Clinical Hold on IND for HEMO-CAR-TLONDON, UK / ACCESSWIRE / June 2, 2023 / Hemogenyx Pharmaceuticals plc…

Hemogenyx Pharmaceuticals Shares Fall After FDA Puts Leukemia Treatment Application on Hold

Hemogenyx Pharmaceuticals Shares Fall After FDA Puts Leukemia Treatment Application on Hold...…

Hemogenyx Pharmaceuticals PLC Announces Final Results for the Year Ended 31 December 2022

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF LAW…

Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Analytical Release Tests Completed

LONDON, UK / ACCESSWIRE / March 23, 2023 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company") (LSE:HEMO), the biopharmaceutical…

Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights

Total Voting RightsLONDON, UK / ACCESSWIRE / February 28, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new…

Hemogenyx raises GBP4 million in share placing for Hemo-CAR-T product

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hemogenyx Pharmaceuticals Shares Fall on Discounted Fund Raising

Hemogenyx Pharmaceuticals Shares Fall on Discounted Fund Raising...…

IN BRIEF: Hemogenyx completes process run for HEMO-CAR-T manufacture

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hemogenyx Pharmaceuticals rallies 35% following encouraging ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Hemogenyx shares up on single target protein virus treatment finding

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

HemoGenyx Shares Rise After Target Protein Discovery for Viral Treatment

HemoGenyx Shares Rise After Target Protein Discovery for Viral Treatment...…

IN BRIEF: Hemogenyx Pharma second process qualification run successful

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hemogenyx makes final development run of HEMO-CAR-T cell manufacture

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hemogenyx Pharmaceuticals Shares Jump on HEMO-CAR-T Cell Update

Hemogenyx Pharmaceuticals Shares Jump on HEMO-CAR-T Cell Update...…